 Rachel McMahan
Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 8 | 2025 | 286 | 1.790 |
Why?
| | Gastrointestinal Microbiome | 6 | 2025 | 641 | 1.510 |
Why?
| | Dysbiosis | 5 | 2025 | 169 | 1.190 |
Why?
| | Ethanol | 9 | 2024 | 589 | 1.190 |
Why?
| | Inflammation | 10 | 2025 | 2736 | 1.000 |
Why?
| | Feces | 3 | 2025 | 440 | 0.980 |
Why?
| | Alcohol Drinking | 5 | 2025 | 764 | 0.900 |
Why?
| | Intestines | 3 | 2022 | 348 | 0.890 |
Why?
| | Public Opinion | 2 | 2023 | 64 | 0.860 |
Why?
| | Pneumonia | 3 | 2025 | 616 | 0.830 |
Why?
| | Hepacivirus | 5 | 2017 | 235 | 0.610 |
Why?
| | Receptors, Antigen, T-Cell | 6 | 2017 | 704 | 0.600 |
Why?
| | Non-alcoholic Fatty Liver Disease | 5 | 2020 | 261 | 0.570 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2024 | 573 | 0.560 |
Why?
| | Liver | 7 | 2024 | 1839 | 0.560 |
Why?
| | Alcoholism | 5 | 2024 | 766 | 0.520 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2016 | 217 | 0.480 |
Why?
| | T-Lymphocytes | 7 | 2017 | 1928 | 0.450 |
Why?
| | Mice | 26 | 2025 | 16937 | 0.450 |
Why?
| | Fatty Liver | 2 | 2013 | 231 | 0.440 |
Why?
| | Mice, Inbred C57BL | 13 | 2025 | 5440 | 0.420 |
Why?
| | T-Lymphocytes, Cytotoxic | 2 | 2010 | 169 | 0.400 |
Why?
| | Macrophages | 8 | 2024 | 1480 | 0.390 |
Why?
| | Hepatitis C, Chronic | 2 | 2011 | 153 | 0.380 |
Why?
| | Alcoholic Intoxication | 2 | 2023 | 63 | 0.380 |
Why?
| | Cancer Vaccines | 3 | 2010 | 164 | 0.380 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2016 | 186 | 0.370 |
Why?
| | Monocytes | 3 | 2013 | 551 | 0.370 |
Why?
| | Animals | 31 | 2025 | 35361 | 0.370 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 207 | 0.360 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2010 | 182 | 0.330 |
Why?
| | Age Factors | 4 | 2025 | 3144 | 0.310 |
Why?
| | Cytokines | 5 | 2025 | 2017 | 0.300 |
Why?
| | Major Histocompatibility Complex | 3 | 2017 | 230 | 0.290 |
Why?
| | Lymphocyte Activation | 4 | 2007 | 1106 | 0.290 |
Why?
| | Antigens, CD | 1 | 2010 | 489 | 0.290 |
Why?
| | Permeability | 3 | 2022 | 157 | 0.280 |
Why?
| | Glycerophospholipids | 2 | 2025 | 34 | 0.280 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4063 | 0.280 |
Why?
| | Macrophages, Alveolar | 3 | 2022 | 389 | 0.270 |
Why?
| | Myelin Basic Protein | 2 | 2003 | 45 | 0.260 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2024 | 362 | 0.250 |
Why?
| | Membrane Proteins | 2 | 2013 | 1119 | 0.240 |
Why?
| | Kupffer Cells | 2 | 2019 | 49 | 0.240 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2025 | 69 | 0.230 |
Why?
| | Immunity, Innate | 2 | 2024 | 804 | 0.230 |
Why?
| | Azepines | 1 | 2024 | 89 | 0.230 |
Why?
| | Immunity | 1 | 2025 | 139 | 0.220 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2024 | 51 | 0.220 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2024 | 129 | 0.220 |
Why?
| | Diet, Western | 1 | 2024 | 79 | 0.220 |
Why?
| | Graft Rejection | 1 | 2007 | 598 | 0.210 |
Why?
| | Binge Drinking | 1 | 2023 | 37 | 0.210 |
Why?
| | Triazoles | 1 | 2024 | 152 | 0.210 |
Why?
| | Hawaii | 1 | 2023 | 32 | 0.210 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 586 | 0.200 |
Why?
| | alpha-Defensins | 1 | 2022 | 10 | 0.200 |
Why?
| | Tryptophan | 1 | 2024 | 179 | 0.200 |
Why?
| | Cytotoxicity, Immunologic | 4 | 2013 | 220 | 0.200 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2022 | 42 | 0.190 |
Why?
| | Delirium | 1 | 2023 | 78 | 0.190 |
Why?
| | Galectins | 2 | 2013 | 22 | 0.190 |
Why?
| | Tight Junctions | 1 | 2021 | 75 | 0.180 |
Why?
| | Lung | 5 | 2024 | 3931 | 0.180 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 110 | 0.180 |
Why?
| | Cell Cycle Proteins | 1 | 2024 | 586 | 0.180 |
Why?
| | Intestinal Mucosa | 3 | 2021 | 590 | 0.180 |
Why?
| | Astrocytes | 1 | 2022 | 201 | 0.170 |
Why?
| | Hepatitis C | 2 | 2016 | 238 | 0.170 |
Why?
| | Diet, High-Fat | 3 | 2020 | 239 | 0.170 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 127 | 0.170 |
Why?
| | Boston | 1 | 2020 | 87 | 0.170 |
Why?
| | Nuclear Proteins | 1 | 2024 | 663 | 0.170 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 61 | 0.170 |
Why?
| | Humans | 27 | 2025 | 129652 | 0.170 |
Why?
| | Glomerulonephritis | 2 | 2018 | 46 | 0.160 |
Why?
| | Male | 17 | 2025 | 63682 | 0.160 |
Why?
| | Myocardium | 1 | 2024 | 980 | 0.160 |
Why?
| | Cholesterol, Dietary | 1 | 2019 | 18 | 0.160 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 11 | 0.160 |
Why?
| | Perilipin-2 | 1 | 2019 | 36 | 0.150 |
Why?
| | Congresses as Topic | 1 | 2020 | 216 | 0.150 |
Why?
| | Osteopontin | 1 | 2018 | 31 | 0.150 |
Why?
| | Gastrointestinal Tract | 1 | 2020 | 185 | 0.150 |
Why?
| | Liver Diseases | 1 | 2021 | 290 | 0.150 |
Why?
| | Hepatocytes | 1 | 2019 | 216 | 0.140 |
Why?
| | Kidney Glomerulus | 1 | 2018 | 109 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1198 | 0.140 |
Why?
| | Myocardial Infarction | 1 | 2024 | 1022 | 0.140 |
Why?
| | Interleukin-10 | 2 | 2024 | 304 | 0.140 |
Why?
| | Sevelamer | 1 | 2016 | 9 | 0.130 |
Why?
| | Immunotherapy | 3 | 2017 | 592 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2016 | 200 | 0.130 |
Why?
| | Transcription Factors | 1 | 2024 | 1651 | 0.130 |
Why?
| | Receptor, Adenosine A2A | 1 | 2016 | 20 | 0.130 |
Why?
| | Adenosine A2 Receptor Agonists | 1 | 2016 | 21 | 0.130 |
Why?
| | Antigens, Neoplasm | 2 | 2010 | 309 | 0.130 |
Why?
| | Mice, Inbred BALB C | 4 | 2010 | 1245 | 0.130 |
Why?
| | Neoplasms | 2 | 2008 | 2470 | 0.130 |
Why?
| | Genomic Instability | 1 | 2016 | 48 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 730 | 0.120 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 2 | 2013 | 30 | 0.110 |
Why?
| | Pregnancy | 2 | 2024 | 6402 | 0.110 |
Why?
| | Fructokinases | 1 | 2013 | 31 | 0.110 |
Why?
| | Ligands | 3 | 2023 | 622 | 0.110 |
Why?
| | Mice, Knockout | 5 | 2024 | 2871 | 0.110 |
Why?
| | Female | 12 | 2025 | 68777 | 0.110 |
Why?
| | Mannose-Binding Lectins | 1 | 2013 | 11 | 0.100 |
Why?
| | Sucrose | 1 | 2013 | 99 | 0.100 |
Why?
| | Mice, Obese | 1 | 2013 | 59 | 0.100 |
Why?
| | Antibodies, Blocking | 2 | 2010 | 33 | 0.100 |
Why?
| | Lectins, C-Type | 1 | 2013 | 71 | 0.100 |
Why?
| | Biomarkers | 2 | 2024 | 3973 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 480 | 0.100 |
Why?
| | Cyclic AMP | 1 | 2013 | 237 | 0.100 |
Why?
| | Macrophage Activation | 1 | 2013 | 189 | 0.090 |
Why?
| | Chemokines | 2 | 2023 | 226 | 0.090 |
Why?
| | Herpesviridae Infections | 1 | 2013 | 141 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 375 | 0.090 |
Why?
| | Receptors, Cell Surface | 1 | 2013 | 380 | 0.090 |
Why?
| | Conserved Sequence | 1 | 2011 | 227 | 0.090 |
Why?
| | Genome, Viral | 1 | 2011 | 129 | 0.090 |
Why?
| | Aging | 3 | 2024 | 1776 | 0.080 |
Why?
| | Peptide Library | 2 | 2010 | 84 | 0.080 |
Why?
| | Vaccines, Subunit | 1 | 2010 | 48 | 0.080 |
Why?
| | Killer Cells, Natural | 1 | 2013 | 427 | 0.080 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2010 | 90 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1085 | 0.080 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2010 | 232 | 0.080 |
Why?
| | Viral Proteins | 1 | 2011 | 328 | 0.080 |
Why?
| | Ischemia | 1 | 2011 | 406 | 0.070 |
Why?
| | Kidney | 2 | 2016 | 1385 | 0.070 |
Why?
| | T-Lymphocyte Subsets | 1 | 2010 | 412 | 0.070 |
Why?
| | Amino Acid Sequence | 3 | 2017 | 2058 | 0.070 |
Why?
| | Baculoviridae | 1 | 2008 | 44 | 0.070 |
Why?
| | Cloning, Molecular | 3 | 2004 | 524 | 0.070 |
Why?
| | H-2 Antigens | 1 | 2008 | 115 | 0.070 |
Why?
| | Insecta | 1 | 2008 | 65 | 0.070 |
Why?
| | Up-Regulation | 1 | 2010 | 840 | 0.070 |
Why?
| | Cross Reactions | 2 | 2017 | 132 | 0.070 |
Why?
| | Young Adult | 3 | 2025 | 12427 | 0.060 |
Why?
| | Rats, Inbred Lew | 2 | 2003 | 110 | 0.060 |
Why?
| | Genetic Variation | 1 | 2011 | 937 | 0.060 |
Why?
| | Drug Design | 1 | 2006 | 156 | 0.060 |
Why?
| | Immune Tolerance | 1 | 2008 | 355 | 0.060 |
Why?
| | Colonic Neoplasms | 1 | 2008 | 243 | 0.060 |
Why?
| | Obesity | 1 | 2019 | 2883 | 0.060 |
Why?
| | Cholera Toxin | 1 | 2025 | 31 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 510 | 0.060 |
Why?
| | Haptoglobins | 1 | 2025 | 52 | 0.060 |
Why?
| | Bacteroidetes | 1 | 2024 | 23 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2023 | 720 | 0.060 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2024 | 21 | 0.060 |
Why?
| | Protein Precursors | 1 | 2025 | 127 | 0.060 |
Why?
| | Receptors, Interleukin-2 | 1 | 2004 | 66 | 0.060 |
Why?
| | Signal Transduction | 3 | 2024 | 4925 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2011 | 790 | 0.050 |
Why?
| | Ileum | 1 | 2024 | 116 | 0.050 |
Why?
| | Fatty Acids, Volatile | 1 | 2024 | 57 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2548 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2004 | 1304 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2010 | 2391 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2010 | 3381 | 0.050 |
Why?
| | Solubility | 1 | 2003 | 235 | 0.050 |
Why?
| | Aged | 3 | 2023 | 22104 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 33 | 0.050 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2024 | 169 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2010 | 752 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 42 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2010 | 1056 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2024 | 4083 | 0.050 |
Why?
| | Fibroblasts | 2 | 2024 | 948 | 0.050 |
Why?
| | Occludin | 1 | 2021 | 11 | 0.050 |
Why?
| | Adult | 4 | 2025 | 35577 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2023 | 280 | 0.050 |
Why?
| | Autoimmunity | 1 | 2007 | 862 | 0.050 |
Why?
| | Malondialdehyde | 1 | 2021 | 28 | 0.050 |
Why?
| | Molecular Sequence Data | 2 | 2003 | 2832 | 0.050 |
Why?
| | Colon | 1 | 2023 | 254 | 0.050 |
Why?
| | Cell Line | 3 | 2017 | 2781 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 2021 | 88 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 653 | 0.040 |
Why?
| | Lipid Peroxidation | 1 | 2021 | 151 | 0.040 |
Why?
| | Middle Aged | 3 | 2024 | 31155 | 0.040 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 840 | 0.040 |
Why?
| | Intercellular Junctions | 1 | 2020 | 39 | 0.040 |
Why?
| | Streptococcus pneumoniae | 1 | 2022 | 159 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 27 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 2021 | 153 | 0.040 |
Why?
| | Mice, Transgenic | 3 | 2011 | 2119 | 0.040 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2001 | 59 | 0.040 |
Why?
| | Histocompatibility Antigens | 1 | 2001 | 107 | 0.040 |
Why?
| | Epitopes | 2 | 2017 | 470 | 0.040 |
Why?
| | Organ Specificity | 1 | 2020 | 296 | 0.040 |
Why?
| | Interferon-gamma | 3 | 2010 | 770 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2001 | 206 | 0.040 |
Why?
| | Glutathione | 1 | 2021 | 348 | 0.040 |
Why?
| | Escherichia coli | 1 | 2003 | 774 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2023 | 1502 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7086 | 0.040 |
Why?
| | Hepatitis | 1 | 2019 | 47 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 317 | 0.040 |
Why?
| | Gene Expression | 1 | 2003 | 1472 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 277 | 0.040 |
Why?
| | Urinary Tract | 1 | 2018 | 38 | 0.040 |
Why?
| | Peptides | 2 | 2017 | 925 | 0.040 |
Why?
| | Isoantigens | 1 | 2017 | 13 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 613 | 0.040 |
Why?
| | HLA-A2 Antigen | 1 | 2017 | 48 | 0.030 |
Why?
| | Molecular Mimicry | 1 | 2017 | 38 | 0.030 |
Why?
| | Hippocampus | 1 | 2022 | 874 | 0.030 |
Why?
| | Rats | 2 | 2003 | 5500 | 0.030 |
Why?
| | Jurkat Cells | 1 | 2017 | 134 | 0.030 |
Why?
| | Viral Nonstructural Proteins | 1 | 2017 | 58 | 0.030 |
Why?
| | Bacteria | 1 | 2023 | 821 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 611 | 0.030 |
Why?
| | Glomerular Basement Membrane | 1 | 2016 | 7 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 495 | 0.030 |
Why?
| | Neutrophils | 1 | 2022 | 1205 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1367 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2016 | 857 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3076 | 0.030 |
Why?
| | Protein Domains | 1 | 2017 | 253 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2017 | 436 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2019 | 497 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 14518 | 0.030 |
Why?
| | Antigens, Viral | 1 | 2016 | 178 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1123 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 592 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2017 | 697 | 0.030 |
Why?
| | Glucose | 1 | 2019 | 1003 | 0.030 |
Why?
| | Muromegalovirus | 1 | 2013 | 21 | 0.030 |
Why?
| | Fructose | 1 | 2013 | 106 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 887 | 0.030 |
Why?
| | Receptors, Virus | 1 | 2013 | 83 | 0.030 |
Why?
| | Interleukin-15 | 1 | 2013 | 82 | 0.020 |
Why?
| | Interleukin-12 | 1 | 2013 | 118 | 0.020 |
Why?
| | Models, Molecular | 1 | 2017 | 1492 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2635 | 0.020 |
Why?
| | Genes, Viral | 1 | 2011 | 82 | 0.020 |
Why?
| | Entropy | 1 | 2011 | 39 | 0.020 |
Why?
| | Risk Factors | 1 | 2025 | 9765 | 0.020 |
Why?
| | Energy Intake | 1 | 2013 | 461 | 0.020 |
Why?
| | Nucleotides | 1 | 2011 | 122 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2019 | 1165 | 0.020 |
Why?
| | Vaccination | 2 | 2010 | 1348 | 0.020 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 12 | 0.020 |
Why?
| | Spodoptera | 1 | 2010 | 37 | 0.020 |
Why?
| | Immunodominant Epitopes | 1 | 2010 | 28 | 0.020 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 82 | 0.020 |
Why?
| | Weight Gain | 1 | 2013 | 510 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2010 | 138 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 185 | 0.020 |
Why?
| | Histocompatibility Antigen H-2D | 1 | 2008 | 21 | 0.020 |
Why?
| | Cross-Priming | 1 | 2008 | 18 | 0.020 |
Why?
| | CD11c Antigen | 1 | 2008 | 41 | 0.020 |
Why?
| | RNA, Viral | 1 | 2011 | 619 | 0.020 |
Why?
| | Amino Acids | 1 | 2011 | 485 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2142 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2010 | 545 | 0.020 |
Why?
| | Chronic Disease | 1 | 2011 | 1720 | 0.010 |
Why?
| | Silver Staining | 1 | 2004 | 17 | 0.010 |
Why?
| | Dendritic Cells | 1 | 2008 | 478 | 0.010 |
Why?
| | Genes, MHC Class II | 1 | 2004 | 73 | 0.010 |
Why?
| | Coculture Techniques | 1 | 2004 | 226 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3215 | 0.010 |
Why?
| | Cell Lineage | 1 | 2004 | 333 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 958 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 833 | 0.010 |
Why?
| | Time Factors | 1 | 2011 | 6556 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2001 | 135 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2004 | 1156 | 0.010 |
Why?
| | Transfection | 1 | 2001 | 911 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 20394 | 0.010 |
Why?
|
|
McMahan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|